NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Ulcerative Colitis
Date of first enrollment	03/10/2013
Target sample size
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : AJM300 INN of investigational material : Therapeutic category code : 239 Other agents affecting digestive organs Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Mayo score, Safety
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	<= 64age old
Gender	Both
Include criteria	Patients with active-phase ulcerative colitis - The Mayo score of 6 to 10. - Mucosal appearance subscore of 2 or more, and Rectal bleeding subscore of 1 or more - Inadequate response to or intolerance of appropriate conventional therapy
Exclude criteria